Search - tctmd.com

Displaying 461 - 480 of 13264

Sort: Relevancy | Date

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Features

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

Michael O'Riordan

February 19, 2025

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

News Conference News

NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

Yael L. Maxwell

February 18, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Conference News THT 2025

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Todd Neale

February 13, 2025

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

Presentation THT 2025

This Strategy Has Saved the Startup Medical Device Sector

Presenter: William Abraham

February 13, 2025

Presentation THT 2025

Down-Stream Challenges: Reimbursement and Guidelines

Presenter: Philip Adamson

February 13, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Yael L. Maxwell

February 12, 2025

Presentation THT 2025

Position 2: All You Need Is Rate Control

Presenter: Akshay Desai

February 12, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Presenter: Akshay Desai

February 12, 2025

Presentation THT 2025

Under Pressure: The Relationship Between Ambulatory PA Pressure and Mortality in Chronic Heart Failure

Presenter: Akshay Desai

February 12, 2025

Advertisement

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

AEDs, Like Fire Extinguishers, Should Be in Every School, Say Experts

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

AHA Scientific Statement Takes Aim at PAD Pain

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

AIM-POWER: Remote, App-Based Intervention Boosts GDMT Use in HFrEF

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

This Strategy Has Saved the Startup Medical Device Sector

Down-Stream Challenges: Reimbursement and Guidelines

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Intermediate Disease May Be the ‘Sweet Spot’ for T-TEER Survival Benefit

Position 2: All You Need Is Rate Control

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Under Pressure: The Relationship Between Ambulatory PA Pressure and Mortality in Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content